跳至主要内容
临床试验/JPRN-UMIN000000948
JPRN-UMIN000000948已完成1 期

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer - Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells in patients with advanced and recurrent lung cancer

Department of Thoracic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 23 人开始时间: 2007年12月14日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • the presence of active infection; a history of hepatitis; a positive response for hepatitis B surface antigen, or human immunodeficiency virus (HIV), hepatitis C virus, or human T-lymphotrophic virus antibodies; evedence for other malignant diseases; serious cardiac disease, recieived concurrent corticosteroid therapy; pregnancy or lactation; been judged to be inappropriate to participate in this study by principle investigator or co-investigator

研究者

发起方
Department of Thoracic Surgery, Graduate School of Medicine, Chiba University

相似试验

Clinical study of alpha-GalactosylCeramide-pulsed... | 临床试验